DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Buchholz S, Seitz S, Schally AV et al.
Triple-negative breast cancers express receptors for luteinizing
hormone-releasing hormone (LHRH) and respond to LHRH antagonist cetrorelix with
growth inhibition.
Int J Oncol 2009;
35: 789-796
We do not assume any responsibility for the contents of the web pages of other providers.